Cargando…

Individualized medical treatment options in Cushing disease

Cushing disease (CD) is caused by a pituitary tumor which oversecretes adrenocorticotropic hormone (ACTH). It is a serious endocrine disease associated with increased mortality and impaired quality of life. The management of CD remains challenging. Although transsphenoidal surgery is the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilis-Januszewska, Aleksandra, Bogusławska, Anna, Rzepka, Ewelina, Ziaja, Witold, Hubalewska-Dydejczyk, Alicja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755355/ https://www.ncbi.nlm.nih.gov/pubmed/36531477 http://dx.doi.org/10.3389/fendo.2022.1060884

Ejemplares similares

FRI111 Venous Thromboembolism In Cushing Syndrome - A Call For Standardized Anticoagulation Regimen In Hypercortisolism
por: Minasyan, Mari, et al.
Publicado: (2023)

THU099 The Challenging Management Of Silent Corticotroph PitNET—From Very Aggressive To Mild Course Of Disease During Long Follow Up
por: Bogusławska, Anna, et al.
Publicado: (2023)

Adrenal bleeding due to pheochromocytoma - A call for algorithm
por: Rzepka, Ewelina, et al.
Publicado: (2022)

Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg)
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2021)

THU019 Osilodrostat As An Emergency Alternative For Hypercortisolism In A Patient With An Impaired Liver Function
por: Minasyan, Mari, et al.
Publicado: (2023)

THU064 Clinical, Radiological Characteristics And Response To Somatostatin Analogues Of Acromegaly Patients With Different Patterns Of Growth Hormone Response After Oral Glucose Load
por: Godlewska, Magdalena, et al.
Publicado: (2023)

FRI320 The Various Clinical Outcomes Of Giant Prolactinomas In Men
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2023)

Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
por: Opalińska, Marta, et al.
Publicado: (2021)

Traumatic brain injuries induced pituitary dysfunction: a call for algorithms
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2020)

Pregnancy, thyroid, and the potential use of selenium
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2019)

Diverse Manifestation of Acromegaly With Suspicion of Ectopic GHRH Secretion. Report of Two Cases
por: Godlewska, Magdalena, et al.
Publicado: (2021)

Ectopic ACTH syndrome of different origin—Diagnostic approach and clinical outcome. Experience of one Clinical Centre
por: Paleń-Tytko, Joanna Ewelina, et al.
Publicado: (2020)

One Fourth of Adult Patients With Acromegaly Have Tall Stature With Similar Frequency in Males And Females
por: Bogusławska, Anna, et al.
Publicado: (2021)

Intrasellar Cavernous Hemangioma, a Rare Condition Causing Both Radiological And Clinical Difficulties- a Case Report
por: Nowak, Andrzej Jerzy, et al.
Publicado: (2021)

Heterogeneity of the Clinical Presentation of the MEN1 LRG_509 c.781C>T (p.Leu261Phe) Variant Within a Three-Generation Family
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2021)

Pituitary insufficiency following traumatic thoracic injury in an adolescent male patient: A case report and literature review
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2017)

Diversity of Pathological Conditions Affecting Pituitary Stalk
por: Kluczyński, Łukasz, et al.
Publicado: (2021)

Editorial: Insights in adrenal endocrinology: 2023
por: Maciejczyk, Mateusz, et al.
Publicado: (2023)

Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?
por: Sowa-Staszczak, Anna, et al.
Publicado: (2021)

AIP gene germline variants in adult Polish patients with apparently sporadic pituitary macroadenomas
por: Trofimiuk-Müldner, Małgorzata, et al.
Publicado: (2023)

Testing of Adrenal Axis Function in Patients With Combined Pituitary Hormone Deficiency Caused by PROP1 Mutation
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2021)

Pituitary Stalk Lesions - Single Center Long Term Observation
por: Kluczynski, Lukasz, et al.
Publicado: (2021)

Medical treatment of Cushing’s disease with concurrent diabetes mellitus
por: Mehlich, Anna, et al.
Publicado: (2023)

Potential value of pre- and post-therapy [68Ga]Ga-DOTA-TATE PET/CT in the prognosis of response to PRRT in disseminated neuroendocrine tumors
por: Opalińska, Marta, et al.
Publicado: (2022)

Predictors of completing a primary health care diabetes prevention intervention programme in people at high risk of type 2 diabetes: Experiences of the DE-PLAN project
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2018)

Determinants of weight outcomes in type 2 diabetes prevention intervention in primary health care setting (the DE-PLAN project)
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2018)

Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2017)

Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
por: Pivonello, Rosario, et al.
Publicado: (2020)

Predictors of long term weight loss maintenance in patients at high risk of type 2 diabetes participating in a lifestyle intervention program in primary health care: The DE-PLAN study
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2018)

Randomized Trial of Osilodrostat for the Treatment of Cushing Disease
por: Gadelha, Mônica, et al.
Publicado: (2022)

Effectiveness of Medical Treatment of Cushing’s Disease: A Systematic Review and Meta-Analysis
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
por: Kos-Kudła, Beata, et al.
Publicado: (2017)

Treatment Options in Cushing’s Disease
por: Rizk, Ahmed, et al.
Publicado: (2012)

How far are we from understanding the genetic basis of Hashimoto’s thyroiditis?
por: Hubalewska-Dydejczyk, Alicja
Publicado: (2013)

Cushing’s syndrome is associated with altered adipokine profile
por: Dadej, Daniela, et al.
Publicado: (2022)

New options for the medical treatment of Cushing's syndrome
por: Trainer, Peter J.
Publicado: (2013)

The effectiveness of a community-based, type 2 diabetes prevention programme on health-related quality of life. The DE-PLAN study
por: Karamanakos, Georgios, et al.
Publicado: (2019)

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
por: Gao, Chang, et al.
Publicado: (2023)

The development of guidelines for management of thyroid diseases in pregnancy – current status
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2015)

Clinical results of radionuclide therapy of neuroendocrine tumours with (90)Y-DOTATATE and tandem (90)Y/(177)Lu-DOTATATE: which is a better therapy option?
por: Kunikowska, Jolanta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_86go9uf0gej1p5i1besj9o6nag